We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+3.09%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$27.1B
AUM Growth
+$1.07B
Cap. Flow
+$498M
Cap. Flow %
1.84%
Top 10 Hldgs %
21.61%
Holding
3,481
New
179
Increased
1,545
Reduced
1,498
Closed
172
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MPV
3076
Barings Participation Investors
MPV
$175M
$173K ﹤0.01%
10,482
+47
+0.5% +$740
PMX
3077
DELISTED
PIMCO Municipal Income Fund III
PMX
$173K ﹤0.01%
21,914
MAC icon
3078
Macerich
MAC
$6.99B
$172K ﹤0.01%
11,113
-8,362
-43% -$128K
BCX icon
3079
BlackRock Resources & Commodities Strategy Trust
BCX
$965M
$171K ﹤0.01%
18,587
+2,475
+15% +$22.9K
EMF
3080
Templeton Emerging Markets Fund
EMF
$332M
$171K ﹤0.01%
13,801
-142
-1% -$1.72K
MMT
3081
Aberdeen Multi-Market Income Fund
MMT
$244M
$171K ﹤0.01%
36,441
+3,856
+12% +$17.7K
DSU icon
3082
BlackRock Debt Strategies Fund
DSU
$599M
$170K ﹤0.01%
15,659
+4,024
+35% +$43.7K
ALTY icon
3083
Global X Alternative Income ETF
ALTY
$45.6M
$169K ﹤0.01%
14,900
-3
-0% -$34
BHC icon
3084
Bausch Health
BHC
$2.32B
$169K ﹤0.01%
24,305
+2,219
+10% +$16.8K
PCK
3085
DELISTED
Pimco California Municipal Income Fund II
PCK
$168K ﹤0.01%
28,766
-1,668
-5% -$9.6K
TFSL icon
3086
TFS Financial
TFSL
$4.89B
$168K ﹤0.01%
+13,291
New +$167K
CX icon
3087
Cemex
CX
$16.2B
$167K ﹤0.01%
26,102
+9,165
+54% +$70.2K
EXK
3088
Endeavour Silver
EXK
$3.14B
$167K ﹤0.01%
47,543
+7,906
+20% +$25.7K
BGC icon
3089
BGC Group
BGC
$5.12B
$162K ﹤0.01%
19,501
-97
-0.5% -$799
EMX
3090
DELISTED
EMX Royalty
EMX
$161K ﹤0.01%
89,586
+69,690
+350% +$133K
TELL
3091
DELISTED
Tellurian Inc.
TELL
$160K ﹤0.01%
230,982
+82,695
+56% +$45.8K
JELD icon
3092
JELD-WEN Holding
JELD
$164M
$159K ﹤0.01%
11,767
-1,441
-11% -$24.1K
BTG icon
3093
B2Gold
BTG
$6.88B
$158K ﹤0.01%
+58,583
New +$158K
CHPT icon
3094
ChargePoint
CHPT
$166M
$158K ﹤0.01%
5,243
+406
+8% +$13.2K
MFA
3095
MFA Financial
MFA
$925M
$158K ﹤0.01%
14,866
+151
+1% +$1.63K
OPRA
3096
Opera Ltd
OPRA
$1.78B
$157K ﹤0.01%
+11,152
New +$158K
SSRM icon
3097
SSR Mining
SSRM
$6.63B
$157K ﹤0.01%
34,745
+11,933
+52% +$61.2K
VZLA
3098
Vizsla Silver
VZLA
$1.33B
$154K ﹤0.01%
+86,184
New +$135K
FBIO icon
3099
Fortress Biotech
FBIO
$91.4M
$152K ﹤0.01%
+88,900
New +$161K
LAND
3100
Gladstone Land Corp
LAND
$353M
$152K ﹤0.01%
11,075
-722
-6% -$9.49K

Similar funds

Cambridge Investment Research Advisors's Q2 2024 Portfolio in Review

As of Q2 2024, Cambridge Investment Research Advisors held 3,481 positions worth $27.1B, up 4.1% from $26B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Cambridge Investment Research Advisors's Q2 2024 filing shows 179 new, 1,545 increased, 1,498 reduced and 172 closed positions. Its largest new stake was Sila Realty Trust: 733,789 shares worth $15.5M. The largest sale was Invesco QQQ Trust, an estimated $99.4M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Cambridge Investment Research Advisors's largest Q2 2024 buy was Sila Realty Trust: 733,789 shares worth $15.5M.
  • Cambridge Investment Research Advisors added most to PIMCO Enhanced Short Maturity Active Exchange-Traded Fund in Q2 2024, an estimated $77.4M increase.
  • Cambridge Investment Research Advisors's biggest Q2 2024 reduction was Invesco QQQ Trust, cutting an estimated $99.4M.
  • Cambridge Investment Research Advisors fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $4.55M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 22% of its $27.1B portfolio in Q2 2024.
  • Cambridge Investment Research Advisors opened 179 new positions and closed 172 in Q2 2024.
  • Cambridge Investment Research Advisors's portfolio value rose 4.1% quarter-over-quarter to $27.1B.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2024, filed 26 Jul 2024.